Education and Qualifications
2001 Post Doctoral Wits University – Johannesburgh/South Africa
1999 PhD in Paediatric Dentistry – University of Sao Paulo/Brazil and Univerity College London/ England
1996 MSc in Paediatric Dentistry – University of Sao Paulo/Brazil
Academic Appointments
Since 2010 Professor of Paediatric Dentistry – University of Sao Paulo/Brazil
2005 Associated Professor in Paediatric Dentistry – University of Sao Paulo/Brazil
Focus of Scientific and Clinical Activities
Dr. Bönecker has been conducting research in the field of Paediatric Dentistry for the past 20 years. He has published more than 90 scholarly articles in professional peer-reviewed journals with international circulation, wrote 68 chapters in books and edited 19 books in Paediatric Dentistry. Dr. Bönecker was Editor of the Brazilian Dental Journal (2010-2015) Associate Editor of the Brazilian Oral Research (2014-2018) and a member of the Editorial Board of the International Journal Paediatric Dentistry (2016-2019). He lectures extensively in Latin America and is a board member of the IAPD since 2011.
Global view on undergraduate education
In order to give a global view on undergraduate education in Paediatric dentistry I will use an electronic questionnaire to collect relevant information about education in paediatric dentistry for dental undergraduate students in many different countries all over the world. Based on the collected data, descriptive results will be shown and a view about what should the dentist know about Paediatric Dentistry will be discussed.
Priv.-Doz. Dr. Dr. Christian Kirschneck
Chief Senior Physician, Department of Orthodontics, University Hospital Regensburg
Education and Qualifications
Graduation from the University of Regensburg in both Dentistry and Molecular Medicine with distinction, Ph.D. in both subjects with the rating “summa cum laude”
2017 Specialist in Orthodontics
2017 Habilitation and Venia legendi for Dentistry at the University of Regensburg
Academic Appointments
2018 Senior Physician, Department of Orthodontics, University Hospital Regensburg (Head: Prof. Dr. Dr. Peter Proff)
since 2018 Member of the Editorial Board of the scientific journal “Annals of Anatomy”
since 2019 Vice President of the Association for Basic Research (AfG) of the German Dental Society (DGZMK)
since 2019 Chief Senior Physician, Department of Orthodontics, University Hospital Regensburg (Head: Prof. Dr. Dr. Peter Proff)
Focus of Scientific and Clinical Activities
Biological-molecular basic research on orthodontic tooth movement
Clinical and epidemiological research on various topics
Author of numerous scientific publications and book contributions (inter alia on molar incisor hypomineralisation, relapse/retention and craniomandibular dysfunctions in orthodontic context)
Management of orthodontic relapse and retention
Adult orthodontics
Extraction and space management – the orthodontic solution
Extraction therapy and orthodontic space closure represent a valid treatment approach for molars affected by molar incisor hypomineralisation (MIH), which also offers certain advantages over prosthetic-restorative therapy, given favourable factors for orthodontic treatment success and a certain severity of hypomineralization with poor long-term prognosis. The decision to extract MIH-affected first molars, however, should not be made by the paediatric dentist or orthodontist alone, but always in conjunction after comprehensive interdisciplinary diagnosis and joint treatment planning, taking into account general, local and secondary factors. Extraction therapy needs to consider not only the MIH pathology itself, but the entire dental and orthodontic status of the patient in question to achieve maximum patient benefit and the individually optimal treatment with minimal adverse effects. For the success of orthodontic extraction therapy in MIH, choosing the optimal time for molar extraction (between 8 and 11.5 years of age), depending on the jaw (upper or lower) as well as the presence or absence of additional dental crowding, is essential. An early referral of children affected by MIH to the orthodontist and an orthodontic examination in the early mixed dentition is recommended to allow for correct timing of orthodontic extraction therapy and space closure in patients, which would benefit from this treatment approach. In this talk the extraction of MIH-affected molars and subsequent orthodontic space closure is discussed as possible treatment option in patients with severe MIH as well as corresponding prerequisites, timing and treatment strategy.
DMD PhD FADM FPFA FICD HonProf
1967 born in Eichstatt, Bavaria, Germany
1992 DMD, University of Erlangen, Germany
2000 PhD, University of Erlangen, Germany
2000-04 Secretary General, German Association of Pediatric Dentistry
2006 Associate Professor, University of Erlangen, Germany
2009 Chairman, Department of Operative Dentistry and Endodontics, University of Marburg
2012-14 President of the German Association of Conservative Dentistry
2012-15 Dean of Marburg Dental School
2015 Editor-in-Chief, Journal of Adhesive Dentistry
2016-18 Dean for Student Affairs in Medicine, Biomedical Science, and Dentistry
2016-19 President elect of the German Association for Maxillofacial Sciences
2019 President of the German Association for Dentistry and Oral Medicine
> 400 publications, > 6000 citations, > 900 lectures in 25 countries
Restorative dentistry and biocompatibility – conflict without solution?
There are several appropriate biomaterials for the restoration of carious and non-carious lesions. However, since amalgam was always alleged to be toxic, also alternative materials get more and more in the focus of so-called biological dentistry. Reports of e.g. Bisphenol-A release from resin-based composites, but also release of aluminum and fluoride from glass ionomer cements are alienating many parents today. Aim of this lecture is to estimate a reasonable rationale for choosing dental biomaterials being a balancing act between toxicology and clinical effectiveness.
Diploma and field competence
Master of Molecular and Cellular Pharmacology, University of Paris 6, France (1990)
PhD on IGF system (Inserm U142 Paris), University of Paris 6, France (1993)
Permanent position at INSERM (CR2) (Inserm U142 Paris) (1995)
Authorization for research direction (HDR), University of Paris 6, France (1998)
Research work on IGF system in cell proliferation and tumorigenesis (1990-2003)
Research work on mRNA decay (cnrs UPR 2167 Gif/Yvette) (2003-2004)
Research on development of mineralized tissues (since 2004)
Group leader on gene – environment relationships and hypomineralyzing pathologies (since 2010)
Director of Research at Inserm (Inserm U1138 Paris) (2016)
Head of the Molecular Oral Pathophysiology Laboratory (since 2018)
Expertises
Local: Conseil du Centre de Recherche des Cordeliers, Conseil UFR Science du Vivant Université Paris-
Diderot, Conseil scientifique de l’UFR Odontologie Université Paris-Diderot
National: Membre du groupe de travail sur les perturbateurs endocriniens à l’ANSES (2017-2020),
Membre du groupe de travail sur les agénésies transverses à Santé Publique France (2019), Comité d’interface Inserm-Odontologie (depuis 2008), Conseil d’administration de la Société Française
d’Endocrinologie (2019-2021), Commission scientifique spécialisée n°6 de l’Inserm (2008-2012),
Comité d’évaluation à l’ANR SV1 (2013-2015)
International: Member of the International Association